PAM
Panagora Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,701
| Closed | -$365K | – | 1117 |
|
|
2025
Q1 | $365K | Hold |
16,701
| – | – | ﹤0.01% | 892 |
|
|
2024
Q4 | $533K | Sell |
16,701
-12,685
| -43% | -$405K | ﹤0.01% | 821 |
|
|
2024
Q3 | $847K | Buy |
29,386
+5,746
| +24% | +$166K | ﹤0.01% | 772 |
|
|
2024
Q2 | $907K | Buy |
+23,640
| New | +$907K | ﹤0.01% | 748 |
|
|
2023
Q2 | – | Sell |
-16,231
| Closed | -$1.07M | – | 1258 |
|
|
2023
Q1 | $1.07M | Hold |
16,231
| – | – | 0.01% | 810 |
|
|
2022
Q4 | $839K | Sell |
16,231
-3,900
| -19% | -$202K | 0.01% | 959 |
|
|
2022
Q3 | $1.38M | Sell |
20,131
-19
| -0.1% | -$1.3K | 0.01% | 729 |
|
|
2022
Q2 | $911K | Buy |
+20,150
| New | +$911K | 0.01% | 918 |
|